z-logo
Premium
Design and synthesis of fluorine‐18 labeled matrix metalloproteinase inhibitors for cancer imaging
Author(s) -
Furumoto Shozo,
Iwata Ren,
Ido Tatsuo
Publication year - 2002
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.616
Subject(s) - chemistry , radiosynthesis , matrix metalloproteinase , positron emission tomography , matrix (chemical analysis) , combinatorial chemistry , matrix metalloproteinase inhibitor , enzyme , metastasis , cancer , radiochemistry , biochemistry , chromatography , nuclear medicine , medicine
Matrix metalloproteinases (MMPs) are key enzymes involved in cancer invasion and metastasis. New 18 F‐labeled MMP inhibitors ( 1a–c ) has been designed and synthesized for cancer imaging by positron emmision tomography. The precursors were synthesized in four steps starting from D ‐form of amino acids. Radiosynthesis of 1a–c were carried out by simple one‐pot synthesis. The resulting radiofluorinated MMP inhibitors were obtained in overall radiochemical yields of 13–43% (EOB, decay corrected) within 60–70 min (including final preparative HPLC separation). Copyright © 2002 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom